Skip to content
OpenCapital
Get started

Journey Medical Corporation DERM Return on assets

Return on assets at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
-0.7%-0.3pp
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-10.5%-35.3pp
PTH
Pelthos Therapeutics Inc.PTHS
-70.5%-30.5pp
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
-11%-4.9pp
HRO
HarrowHROW
-10.5%+5.0pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
21.5%-3.8pp

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M—
Free cash flow-$6.0M—

Valuation

See full
Market cap$194.94M+21.1%
Enterprise value$193.19M+16.4%
P/S3×+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%—
Net margin-14.8%—
FCF margin-43%—

Returns & leverage

See full
Return on equity-36.6%—
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

net income/total assets=-10.9%

Based on trailing twelve months.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's return on assets?
Journey Medical Corporation (DERM) reported return on assets of -10.9% in Q1 2026.
What is the long-term trend for Journey Medical Corporation's return on assets?
Over 3 years (2021 to 2025), Journey Medical Corporation's return on assets has grown at a -39.5% compound annual growth rate (CAGR), from -59% to -13.1%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.